Data Publication

Valencia conducted a feasibility study on 48 patients in the U.S. and New Zealand and that data has been published by the Journal of Urology. With 70% of patients improving in their urgency urinary incontinence by at least 50% and nearly a quarter of patients completely dry in their symptoms, eCoin® demonstrated excellent effectiveness results. Furthermore, the eCoin® device– implanted in the lower leg in a 15 minute office procedure– appears to have a benign safety profile in stark contrast to sacral neuromodulation. eCoin® is an investigational device only and is not approved for sale in any country.